Intussusception risk and health benefits of rotavirus vaccination in Mexico and Brazil

New England Journal of Medicine

Volumn 364, Issue 24, 2011, Pages 2283-2292

  Patel, Manish M ^a   López Collada, Vesta Richardson ^b   Bulhões, Marília Mattos ^a   De Oliveira, Lucia Helena ^q   Márquez, Aurora Bautista ^b   Flannery, Brendan ^h   Esparza Aguilar, Marcelino ^b   Renoiner, Ernesto Isaac Montenegro ^f,g   Luna Cruz, María Edilia ^b   Sato, Helena Keico ⁱ   Hernández Hernández, Luz Del Carmen ^b   Toledo Cortina, Gerardo ^c   Cerón Rodríguez, Magdalena ^d   Osnaya Romero, Neydi ^e,r   Martínez Alcazar, Mario ^f,s   Aguinaga Villasenor, Rocío Gabriela ^a,s   Plascencia Hernández, Arturo ^a,t   Fojaco González, Francisco ^a,u   Rezk, Guillermo Hernández Peredo ^v   Gutierrez Ramírez, Sixto Fortino ^w   Dorame Castillo, Roberto ^x   Tinajero Pizano, Rogelio ^y   Mercado Villegas, Bernice ^z   Barbosa, Marilia Reichelt ^j   Maluf, Eliane Mara Cesário ^k   Ferreira, Lucimar Bozza ^l   De Carvalho, Francisca Maria ^m   Dos Santos, Ana Rosa ^f   Cesar, Eduardo Dolabella ⁿ   De Oliveira, Maria Elisa Paula ^o   Silva, Carmem Lúcia Osterno ^p   Cortes, Maria De Los Angeles ^q   Matus, Cuauhtemoc Ruiz ^q   Tate, Jacqueline ^a   Gargiullo, Paul ^a   Parashar, Umesh D ^a   more..

^a CENTERS FOR DISEASE CONTROL AND PREVENTION   (United States)

^b Ministry of Health   (Mexico)

^c Hospital Pediatrico Moctezuma   (Mexico)

^d HOSPITAL INFANTIL DE MÉXICO FEDERICO GÓMEZ   (Mexico)

^e INSTITUTO NACIONAL DE PEDIATRÍA   (Mexico)

^f MINISTÉRIO DA SAÚDE   (Brazil)

^g UNIVERSITY OF BRASILIA   (Brazil)

^h PAN AMERICAN HEALTH ORGANIZATION   (Brazil)

ⁱ Secretaria de Estado da Saude de Sao Paulo   (Brazil)

^j Programa de Residência Médica   (Brazil)

^k Secretaria de Estado da Saúde do Paraná   (Argentina)

^l Secretaria Municipal de Saúde de Curitiba   (Argentina)

^m Secretaria Municipal de Saude da Cidade do Rio de Janeiro   (Brazil)

ⁿ Secretaria de Estado da Saude de Minas Gerais   (Brazil)

^o Centro Administrativo   (Brazil)

^p Secretaria de Estado da Saúde de Curitiba   (Brazil)

^q PAN AMERICAN HEALTH ORGANIZATION   (United States)

^r Hospital del Nino Morelense   (Mexico)

^s Hospital Infantil Eva Sámano de López Mateos   (Mexico)

^t HOSPITAL CIVIL DE GUADALAJARA FRAY ANTONIO ALCALDE   (Mexico)

^u Hospital Regional de Alta Especialidad Del Niño Dr Rodolfo Nieto Padrón   (Mexico)

^v Centro de Alta Especialidad del Estado de Veracruz Dr Rafael Lucio   (Mexico)

^w Hospital Metropolitano Dr Bernardo Sepúlveda   (Mexico)

^x Hospital Infantil del Estado de Sonora   (Mexico)

^y Hospital General de Leon   (Mexico)

^z Hospital Civil de Tepic Dr Antonio González Guevara   (Mexico)

more..

Author keywords

[No Author keywords available]

Indexed keywords

ROTAVIRUS VACCINE;

ARTICLE; BRAZIL; CASE CONTROL STUDY; CASE STUDY; CONTROLLED STUDY; DIARRHEA; DISEASE ASSOCIATION; DRUG FATALITY; FEMALE; HOSPITALIZATION; HUMAN; INFANT; INFANT MORTALITY; INTUSSUSCEPTION; MAJOR CLINICAL STUDY; MALE; MEXICO; PRIORITY JOURNAL; RISK BENEFIT ANALYSIS; ROTAVIRUS INFECTION;

EID: 79959320244     PISSN: 00284793     EISSN: 15334406     Source Type: Journal    
DOI: 10.1056/NEJMoa1012952     Document Type: Article

References (29)

1. Murphy TV, Gargiullo PM, Massoudi MS, et al. Intussusception among infants given an oral rotavirus vaccine. N Engl J Med 2001;344:564-72. (Pubitemid 32167870)
2. Peter G, Myers MG. Intussusception, rotavirus, and oral vaccines: summary of a workshop. Pediatrics 2002;110(6):e67.
3. Ruiz-Palacios GM, Pérez-Schael I, Velázquez FR, et al. Safety and efficacy of an attenuated vaccine against severe rotavirus gastroenteritis. N Engl J Med 2006;354:11-22. (Pubitemid 43048947)
4. Vesikari T, Matson DO, Dennehy P, et al. Safety and efficacy of a pentavalent human-bovine (WC3) reassortant rotavirus vaccine. N Engl J Med 2006;354:23-33. (Pubitemid 43048948)
5. Rotavirus vaccines. Wkly Epidemiol Rec 2007;82:285-95.
6. Rotavirus vaccines: an update. Wkly Epidemiol Rec 2009;84:533-40.
7. Farrington CP. Relative incidence estimation from case series for vaccine safety evaluation. Biometrics 1995;51:228-35.
8. Idem. Control without separate controls: evaluation of vaccine safety using case-only methods. Vaccine 2004;22:2064-70.
9. Bines JE, Kohl KS, Forster J, et al. Acute intussusception in infants and children as an adverse event following immunization: case definition and guidelines of data collection, analysis, and presentation. Vaccine 2004;22:569-74. (Pubitemid 38114883)
10. Musonda P, Farrington CP, Whitaker HJ. Sample sizes for self-controlled case series studies. Stat Med 2006;25:2618-31. [Erratum, Stat Med 2008;27:4854-5.]
11. Farrington CP, Whitaker HJ, Hocine MN. Case series analysis for censored, perturbed, or curtailed post-event exposures. Biostatistics 2009;10:3-16. (Pubitemid 352847902)
12. Araujo EC, Clemens SA, Oliveira CS, et al. Safety, immunogenicity, and protective efficacy of two doses of RIX4414 live attenuated human rotavirus vaccine in healthy infants. J Pediatr (Rio J) 2007;83:217-24. (Pubitemid 46883821)
13. Salinas B, Pérez Schael I, Linhares AC, et al. Evaluation of safety, immunogenicity and efficacy of an attenuated rotavirus vaccine, RIX4414: a randomized, placebo-controlled trial in Latin American infants. Pediatr Infect Dis J 2005;24:807-16. (Pubitemid 41324890)
14. Linhares AC, Velázquez FR, Pérez-Schael I, et al. Efficacy and safety of an oral live attenuated human rotavirus vaccine against rotavirus gastroenteritis during the first 2 years of life in Latin American infants: a randomised, double-blind, placebo-controlled phase III study. Lancet 2008;371:1181-9. (Pubitemid 351458523)
15. Moser CA, Dolfi DV, Di Vietro ML, Heaton PA, Offit PA, Clark HF. Hypertrophy, hyperplasia, and infectious virus in gut-associated lymphoid tissue of mice after oral inoculation with simian-human or bovine-human reassortant rotaviruses. J Infect Dis 2001;183:1108-11. (Pubitemid 32230960)
16. Meeting of the Global Advisory Committee on Vaccine Safety, December 2010. Wkly Epidemiol Rec 2011;86:38-43.
17. Buttery JP, Danchin MH, Lee KJ, et al. Intussusception following rotavirus vaccine administration: post-marketing surveillance in the National Immunization Program in Australia. Vaccine 2011;29:3061-6.
18. Steele AD, De Vos B, Tumbo J, et al. Co-administration study in South African infants of a live-attenuated oral human rotavirus vaccine (RIX4414) and poliovirus vaccines. Vaccine 2010;28:6542-8.
19. Patel M, Shane AL, Parashar UD, Jiang B, Gentsch JR, Glass RI. Oral rotavirus vaccines: how well will they work where they are needed most? J Infect Dis 2009;200:Suppl 1:S39-S48.
20. Cortese MM, Parashar UD. Prevention of rotavirus gastroenteritis among infants and children: recommendations of the Advisory Committee on Immunization Practices (ACIP). MMWR Recomm Rep 2009;58:1-25. [Erratum, MMWR Recomm Rep 2010;59:1074.]
21. de Palma O, Cruz L, Ramos H, et al. Effectiveness of rotavirus vaccination against childhood diarrhoea in El Salvador: case-control study. BMJ 2010;340:c2825.
22. Richardson V, Hernandez-Pichardo J, Quintanar-Solares M, et al. Effect of rotavirus vaccination on death from childhood diarrhea in Mexico. N Engl J Med 2010;362:299-305.
23. Patel MM, Pedreira C, De Oliveira LH, et al. Association between pentavalent rotavirus vaccine and severe rotavirus diarrhea among children in Nicaragua. JAMA 2009;301:2243-51.
24. Patel MM, Steele D, Gentsch JR, Wecker J, Glass RI, Parashar UD. Realworld impact of rotavirus vaccination. Pediatr Infect Dis J 2011;30:1 Suppl:S1-S5.
25. Simonsen L, Morens D, Elixhauser A, Gerber M, Van Raden M, Blackwelder W. Effect of rotavirus vaccination programme on trends in admission of infants to hospital for intussusception. Lancet 2001;358:1224-9. (Pubitemid 33010847)
26. Macias M, Lopez P, Velazquez FR, Vergara RF, Salmeron J. The Rotavirus vaccine RIX 4414 (Rotarix) is not associated with intussusception in one year old infants. In: Program and abstracts of the 45th Interscience Conference on Antimicrobial Agents and Chemotherapy, Washington, DC, December 16-19, 2005. Washington, DC: American Society for Microbiology, 2005. abstract.
27. Patel MM, Clark AD, Glass RI, et al. Broadening the age restriction for initiating rotavirus vaccination in regions with high rotavirus mortality: benefits of mortality reduction versus risk of fatal intussusception. Vaccine 2009;27:2916-22.
28. Global Advisory Committee on Vaccine Safety, report of meeting held 17-18 June 2009. Wkly Epidemiol Rec 2009;84:325-32.
29. Cortese M. Estimates of benefits and potential risks of Rotavirus vaccination in the US. (http://www.cdc.gov/vaccines/recs/acip/slides-oct10.htm.)